Viewing Study NCT05113459


Ignite Creation Date: 2025-12-24 @ 2:56 PM
Ignite Modification Date: 2025-12-27 @ 11:32 AM
Study NCT ID: NCT05113459
Status: UNKNOWN
Last Update Posted: 2021-11-09
First Post: 2021-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer(RC48-C018)
Sponsor: Guoxin Li
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module